Table 3.
Study | Margins | Sample Size | Histotypes | Tumor Grade | Median Follow Up (Months) | LR Rate | Margin Indipendent Prognostic Factor for LR? | Other Prognostic Factors for LR? | Homogeneous Cohort |
---|---|---|---|---|---|---|---|---|---|
Gundle et al. [29] | R0% R1 R2 |
2217 | All Histotypes | All grades | 65 | 6.0% 17.0% 38.0% |
yes | Grade 3 Depth RT |
no |
Stojadinovic et al. [42] | R0% R1 |
2084 | All histotypes | High- low grade | 50 | 15.2% 28.0% |
yes | Tumor size Histologic grade Retroperitoneal location Fibrosarcoma histologic subtype |
no |
Harati et al. [43] | R0 R1 |
643 | All histotypes | All grades | 64 | 32.9% 63.9% |
yes | Age Histological grade Myxofibrosarcoma Adjuvant RT |
no |
Ahmad et al. [37] | R0% R1 |
382 | All histotypes | All grades | 82 | 7.0% 17.0% |
yes | RT | no |
Bilgeri et al. [35] | R0% R1 |
305 | All Histotypes | Grade 2–3 | 60 | 17.0% 34.0% |
yes | RT | no |
Kainhofer et al. [31] | R0% R1 |
265 | All histotypes | All grades | - | 16.5% 36.7% |
yes | Adjuvant ChT | no |
Le Doussal et al. [44] | R0% R1 |
216 | Infiltrative STS | All grades | 42 | 37.0% | no | RT | no |
Goertz et al. [45] | R0% R1/R2 |
192 | Infiltrative STS | All grades | 61 | 24.3% 50.9% |
yes | Adjuvant RT | yes |
Cates et al. [28] | R0% <1 mm ≥2 mm R1-R2 |
166 | All histotypes | High grade | 51 | 24.0% 12.0% 50.0% |
yes | - | no |
Cates et al. [26] | R0% R1 |
166 | All histotypes | High grade | 49 | 30.0% (no RT) 17.0% (with RT) 17.0% (with RT) |
yes | RT | no |
Iwata et al. [46] | R0% R1 R2 |
145 | All histotypes | Grade 2–3 | 48 | 5.0% 21.0% 15.0% |
yes | Histological infiltration | no |
Sambri et al. [15] | R0% R1 |
129 | Infiltrative STS | Grade 3 | 35 | 18.0% 29.4% |
no | - | yes |
Dadrass et al. [47] | R0% R1/R2 |
42 | Infiltrative STS | All grades | - | 13.0% 85.0% |
yes | - | yes |
LR: local recurrence; RT: radiotherapy; ChT: chemotherapy.